These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1317079)

  • 1. [Is there in Belgium an increase in resistance to the combination amoxicillin/clavulanic acid of Escherichia coli as reference bacteria?].
    Yourassowsky E; Van der Linden MP; MacGilavry GB; Glupczynsky Y
    Acta Clin Belg; 1992; 47(1):15-20. PubMed ID: 1317079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K
    Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sunakawa K; Ishizuka Y
    Jpn J Antibiot; 1985 Feb; 38(2):319-26. PubMed ID: 3892075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of augmentin against clinically important gram-positive and gram-negative bacteria in comparison with other antibiotics.
    Focht J; Klietmann W; Heilmann HD
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Apr; 256(4):523-30. PubMed ID: 6564828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
    Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Appearance of Escherichia coli strain with high production of cephalosporinase during treatment with an amoxicillin and clavulanic acid combination].
    Aubert G; Peyle V; Dumont N; el Fassi M; Dorche G
    Ann Biol Clin (Paris); 1990; 48(7):449-54. PubMed ID: 2278408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Nagata K; Yokoyama M
    Jpn J Antibiot; 1985 Feb; 38(2):263-8. PubMed ID: 4009948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes.
    Fuglesang JE; Bergan T
    Infection; 1983; 11(6):329-35. PubMed ID: 6365790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis.
    Nadler JP; Berger J; Nord JA; Cofsky R; Saxena M
    Chest; 1991 Apr; 99(4):1025-6. PubMed ID: 1901260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcalorimetric, turbidimetric, phase-contrast microscopic, and electron microscopic investigations of the actions of amoxicillin, clavulanic acid and augmentin on amoxicillin-sensitive and amoxicillin-resistant strains of Escherichia coli.
    Semenitz E; Casey PA; Pfaller W; Gstraunthaler G
    Chemotherapy; 1983; 29(3):192-207. PubMed ID: 6347546
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination antibiotic for resistant bacterial strains.
    Pepper GA
    Nurse Pract; 1985 Mar; 10(3):49-50. PubMed ID: 3845395
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules on skin and soft tissue infections in the field of pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
    Jpn J Antibiot; 1985 Feb; 38(2):507-37. PubMed ID: 3892077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy.
    Pedler SJ; Bint AJ
    Antimicrob Agents Chemother; 1985 Apr; 27(4):508-10. PubMed ID: 4004191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of an amoxicillin/clavulanic-acid combination in respiratory tract infection: bacterial resistance and antibiotic therapy].
    Caramia M; Taddei G; Nobilini A
    Minerva Pediatr; 1990; 42(1-2):29-34. PubMed ID: 2186263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of staphylococcal infections.
    Lacey RW
    J Antimicrob Chemother; 1983 Jan; 11(1):3-6. PubMed ID: 6550055
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs recently released in Belgium.
    Harvengt C
    Acta Clin Belg; 1983; 38(4):273-6. PubMed ID: 6415986
    [No Abstract]   [Full Text] [Related]  

  • 20. Amoxicillin-clavulanic acid (Augmentin).
    Med Lett Drugs Ther; 1984 Nov; 26(674):99-100. PubMed ID: 6387417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.